{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T17:01:38Z","timestamp":1789578098873,"version":"build-2803163510"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2018,5,25]],"date-time":"2018-05-25T00:00:00Z","timestamp":1527206400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["K23 AI097225"],"award-info":[{"award-number":["K23 AI097225"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R21 AI119692"],"award-info":[{"award-number":["R21 AI119692"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R21 AI130669"],"award-info":[{"award-number":["R21 AI130669"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R21 AI133330"],"award-info":[{"award-number":["R21 AI133330"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,1,7]]},"DOI":"10.1093\/cid\/ciy458","type":"journal-article","created":{"date-parts":[[2018,5,25]],"date-time":"2018-05-25T03:11:46Z","timestamp":1527217906000},"page":"247-255","source":"Crossref","is-referenced-by-count":60,"title":["Increased Risk of Infectious Complications in Older Patients With Indolent Non-Hodgkin Lymphoma Exposed to Bendamustine"],"prefix":"10.1093","volume":"68","author":[{"given":"Monica","family":"Fung","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Jacobsen","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnold","family":"Freedman","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Prestes","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Brigham and Women\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Farmakiotis","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Warren Alpert Medical School of Brown University, Providence, Rhode Island"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangmei","family":"Gu","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Brigham and Women\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul L","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Brigham and Women\u2019s Hospital, Dana-Farber Cancer Institute, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Koo","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts"},{"name":"Division of Infectious Diseases, Brigham and Women\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,5,25]]},"reference":[{"key":"key\n\t\t\t\t2019010623582243700_CIT0001","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1182\/blood-2005-06-2508","article-title":"Lymphoma incidence patterns by WHO subtype in the United States, 1992\u20132001","volume":"107","author":"Morton","year":"2006","journal-title":"Blood"},{"key":"key\n\t\t\t\t2019010623582243700_CIT0002","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S0140-6736(12)60605-9","article-title":"Non-Hodgkin lymphoma","volume":"380","author":"Shankland","year":"2012","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019010623582243700_CIT0003","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21442","article-title":"Cancer statistics, 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"key\n\t\t\t\t2019010623582243700_CIT0004","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/cncr.24057","article-title":"Bendamustine: a new look at an old drug","volume":"115","author":"Kalaycio","year":"2009","journal-title":"Cancer"},{"key":"key\n\t\t\t\t2019010623582243700_CIT0005","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1053\/j.seminhematol.2011.03.004","article-title":"Bendamustine\u2019s emerging role in the management of lymphoid malignancies","volume":"48(Suppl 1)","author":"Rummel","year":"2011","journal-title":"Semin Hematol"},{"key":"key\n\t\t\t\t2019010623582243700_CIT0006","volume-title":"FDA approval for bendamustine hydrochloride","author":"National Cancer Institute, National Institutes of Health"},{"key":"key\n\t\t\t\t2019010623582243700_CIT0007","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3816\/CLML.2010.n.002","article-title":"Optimal use of bendamustine in chronic lymphocytic leukemia, non-Hodgkin lymphomas, and multiple myeloma: treatment recommendations from an international consensus panel","volume":"10","author":"Cheson","year":"2010","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"key\n\t\t\t\t2019010623582243700_CIT0008","doi-asserted-by":"crossref","first-page":"4473","DOI":"10.1200\/JCO.2008.17.0001","article-title":"Phase II multicenter study of bendamustine plus rituximab in patients with relapsed indolent B-cell and mantle cell non-Hodgkin\u2019s lymphoma","volume":"26","author":"Robinson","year":"2008","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t2019010623582243700_CIT0009","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/cncr.24714","article-title":"Bendamustine is effective therapy in patients with rituximab-refractory, indolent B-cell non-Hodgkin lymphoma: results from a multicenter study","volume":"116","author":"Kahl","year":"2010","journal-title":"Cancer"},{"key":"key\n\t\t\t\t2019010623582243700_CIT0010","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1200\/JCO.2012.45.3308","article-title":"Phase II study of bendamustine in relapsed and refractory Hodgkin lymphoma","volume":"31","author":"Moskowitz","year":"2013","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t2019010623582243700_CIT0011","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.2165\/11209510-000000000-00000","article-title":"Bendamustine: a review of its use in the management of chronic lymphocytic leukaemia, rituximab-refractory indolent non-Hodgkin\u2019s lymphoma and multiple myeloma","volume":"72","author":"Hoy","year":"2012","journal-title":"Drugs"},{"key":"key\n\t\t\t\t2019010623582243700_CIT0012","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/S0140-6736(12)61763-2","article-title":"Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial","volume":"381","author":"Rummel","year":"2013","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019010623582243700_CIT0013","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s00277-016-2668-0","article-title":"Bendamustine plus rituximab versus R-CHOP as first-line treatment for patients with indolent non-Hodgkin\u2019s lymphoma: evidence from a multicenter, retrospective study","volume":"95","author":"Mondello","year":"2016","journal-title":"Ann Hematol"},{"key":"key\n\t\t\t\t2019010623582243700_CIT0014","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S1470-2045(15)00447-7","article-title":"Bendamustine plus rituximab versus fludarabine plus rituximab for patients with relapsed indolent and mantle-cell lymphomas: a multicentre, randomised, open-label, non-inferiority phase 3 trial","volume":"17","author":"Rummel","year":"2016","journal-title":"Lancet Oncol"},{"key":"key\n\t\t\t\t2019010623582243700_CIT0015","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1182\/blood-2013-11-531327","article-title":"Randomized trial of bendamustine-rituximab or R-CHOP\/R-CVP in first-line treatment of indolent NHL or MCL: the BRIGHT study","volume":"123","author":"Flinn","year":"2014","journal-title":"Blood"},{"key":"key\n\t\t\t\t2019010623582243700_CIT0016","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1007\/s00277-014-2135-8","article-title":"Lymphocyte recovery is impaired in patients with chronic lymphocytic leukemia and indolent non-Hodgkin lymphomas treated with bendamustine plus rituximab","volume":"93","author":"Garc\u00eda Mu\u00f1oz","year":"2014","journal-title":"Ann Hematol"},{"key":"key\n\t\t\t\t2019010623582243700_CIT0017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10428194.2015.1026818","article-title":"Sustained CD4 and CD8 lymphopenia after rituximab maintenance therapy following bendamustine and rituximab combination therapy for lymphoma","volume":"56","author":"Yutaka","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"key\n\t\t\t\t2019010623582243700_CIT0018","doi-asserted-by":"crossref","first-page":"e362","DOI":"10.1038\/bcj.2015.86","article-title":"Prolonged lymphocytopenia after bendamustine therapy in patients with relapsed or refractory indolent B-cell and mantle cell lymphoma","volume":"5","author":"Saito","year":"2015","journal-title":"Blood Cancer J"},{"key":"key\n\t\t\t\t2019010623582243700_CIT0019","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.3109\/10428194.2012.739285","article-title":"Bendamustine can severely impair T-cell immunity against cytomegalovirus","volume":"54","author":"Hosoda","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"key\n\t\t\t\t2019010623582243700_CIT0020","doi-asserted-by":"crossref","first-page":"e223","DOI":"10.1016\/j.leukres.2011.07.014","article-title":"Pneumocystis jirovecii pneumonia as a complication of bendamustine in a patient receiving bendamustine plus rituximab for marginal zone lymphoma","volume":"35","author":"Carter","year":"2011","journal-title":"Leuk Res"},{"key":"key\n\t\t\t\t2019010623582243700_CIT0021","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/ccr3.195","article-title":"Pneumocystis jiroveci prophylaxis in patients undergoing bendamustine treatment: the need for a standardized protocol","volume":"3","author":"Abkur","year":"2015","journal-title":"Clin Case Rep"},{"key":"key\n\t\t\t\t2019010623582243700_CIT0022","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00277-011-1307-z","article-title":"Severe CMV reactivation and gastritis during treatment of follicular lymphoma with bendamustine","volume":"91","author":"Lim","year":"2012","journal-title":"Ann Hematol"},{"key":"key\n\t\t\t\t2019010623582243700_CIT0023","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1056\/NEJMoa1614598","article-title":"Obinutuzumab for the first-line treatment of follicular lymphoma","volume":"377","author":"Marcus","year":"2017","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019010623582243700_CIT0024","doi-asserted-by":"crossref","first-page":"IV3","DOI":"10.1097\/00005650-200208001-00002","article-title":"Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population","volume":"40","author":"Warren","year":"2002","journal-title":"Med Care"},{"key":"key\n\t\t\t\t2019010623582243700_CIT0025","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1097\/MLR.0b013e31828fad9f","article-title":"Algorithm for identifying chemotherapy\/biological regimens for metastatic colon cancer in SEER-Medicare","volume":"53","author":"Bikov","year":"2015","journal-title":"Med Care"},{"key":"key\n\t\t\t\t2019010623582243700_CIT0026","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1007\/s00384-014-1972-1","article-title":"Evaluation of four comorbidity indices and Charlson comorbidity index adjustment for colorectal cancer patients","volume":"29","author":"Marventano","year":"2014","journal-title":"Int J Colorectal Dis"},{"key":"key\n\t\t\t\t2019010623582243700_CIT0027","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/S0895-4356(00)00256-0","article-title":"Development of a comorbidity index using physician claims data","volume":"53","author":"Klabunde","year":"2000","journal-title":"J Clin Epidemiol"},{"key":"key\n\t\t\t\t2019010623582243700_CIT0028","first-page":"CD004386","article-title":"Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy","volume":"1","author":"Gafter-Gvili","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"key\n\t\t\t\t2019010623582243700_CIT0029","first-page":"CD005590","article-title":"Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients","volume":"10","author":"Stern","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"key\n\t\t\t\t2019010623582243700_CIT0030","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/S0140-6736(05)66553-1","article-title":"Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomised controlled trials","volume":"365","author":"Hodson","year":"2005","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019010623582243700_CIT0031","first-page":"CD006706","article-title":"Interventions for the prevention and treatment of herpes simplex virus in patients being treated for cancer","volume":"1","author":"Glenny","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"key\n\t\t\t\t2019010623582243700_CIT0032","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1086\/514744","article-title":"Itraconazole prophylaxis for fungal infections in patients with advanced human immunodeficiency virus infection: randomized, placebo-controlled, double-blind study. National Institute of Allergy and Infectious Diseases Mycoses Study Group","volume":"28","author":"McKinsey","year":"1999","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019010623582243700_CIT0033","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1007\/s00280-013-2112-2","article-title":"Severe and prolonged lymphopenia observed in patients treated with bendamustine and erlotinib for metastatic triple negative breast cancer","volume":"71","author":"Layman","year":"2013","journal-title":"Cancer Chemother Pharmacol"},{"key":"key\n\t\t\t\t2019010623582243700_CIT0034","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.clml.2017.06.033","article-title":"Extended follow-up of patients treated with bendamustine for lymphoid malignancies","volume":"17","author":"Penne","year":"2017","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"key\n\t\t\t\t2019010623582243700_CIT0035","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/hon.2350","article-title":"Bendamustine-associated infections-systematic review and meta-analysis of randomized controlled trials","volume":"35","author":"Gafter-Gvili","year":"2017","journal-title":"Hematol Oncol"},{"key":"key\n\t\t\t\t2019010623582243700_CIT0036","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1097\/MLR.0b013e31823ab60f","article-title":"Identifying specific chemotherapeutic agents in Medicare data: a validation study","volume":"51","author":"Lund","year":"2013","journal-title":"Med Care"},{"key":"key\n\t\t\t\t2019010623582243700_CIT0037","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1038\/bjc.2014.173","article-title":"Common infection-related conditions and risk of lymphoid malignancies in older individuals","volume":"110","author":"Anderson","year":"2014","journal-title":"Br J Cancer"},{"key":"key\n\t\t\t\t2019010623582243700_CIT0038","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.canep.2013.10.009","article-title":"Community-acquired infections and their association with myeloid malignancies","volume":"38","author":"Titmarsh","year":"2014","journal-title":"Cancer Epidemiol"},{"key":"key\n\t\t\t\t2019010623582243700_CIT0039","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1086\/524324","article-title":"Comparison of the use of administrative data and an active system for surveillance of invasive aspergillosis","volume":"29","author":"Chang","year":"2008","journal-title":"Infect Control Hosp Epidemiol"},{"key":"key\n\t\t\t\t2019010623582243700_CIT0040","doi-asserted-by":"crossref","first-page":"107892","DOI":"10.1100\/2012\/107892","article-title":"Prognostic assessment in patients with indolent B-cell lymphomas","volume":"2012","author":"Arcaini","year":"2012","journal-title":"ScientificWorldJournal"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/68\/2\/247\/27407465\/ciy458.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T00:04:32Z","timestamp":1720310672000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/68\/2\/247\/5003587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,25]]},"references-count":40,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,5,25]]},"published-print":{"date-parts":[[2019,1,7]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciy458","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,1,15]]},"published":{"date-parts":[[2018,5,25]]}}}